<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Gynecologic Cancer

Gynecologic Cancer    Endometrial Cancer    Clinical Trials

A Clinical Trial at the CU Cancer Center Kept Charlotte Butler’s Uterine Cancer at Bay

According to her race medals, Charlotte Butler has walked all over the place. On trails in Spain, France, Ireland, and the Netherlands, not to mention the Rocky Mountains and other spots in the U.S.


Author Greg Glasgow | Publish Date June 10, 2024
Full Story

Research    Gynecologic Cancer    Magazine    Ovarian Cancer

Innovations in Ovarian Cancer Research

Ovarian cancer is a growing area of research at the University of Colorado Cancer Center. A newly formed Ovarian Cancer Innovations Group, envisioned by Saketh Guntupalli, MD, and led by Kian Behbakht, MD, MBA, is taking a multipronged approach to studying the disease.


Author Greg Glasgow | Publish Date November 27, 2023
Full Story

Research    Community    Awareness    Gynecologic Cancer    Vaccinations    Cervical Cancer

HPV Education and Patient Navigation Project Seeks to Raise Awareness of Need for HPV Vaccine

Even as exciting developments are happening in cervical cancer research, an estimated 14,100 new cases of invasive cervical cancer will be diagnosed in the United States this year.


Author Rachel Sauer | Publish Date February 16, 2022
Full Story

Gynecologic Cancer    Vaccinations    Cervical Cancer

Three Things to Know About the HPV Vaccine and Cervical Cancer

January is Cervical Cancer Awareness Month, and CU Cancer Center member Lindsay Brubaker, MD, wants everyone to be aware of the relationship between cervical cancer and the human papillomavirus (HPV), a sexually-transmitted disease that causes the vast majority of cervical cancers. The current HPV vaccine protects against seven predominant strains of the virus that cause cancer, as well as the two that cause genital warts.


Author Cancer Center | Publish Date January 22, 2021
Full Story

Press Coverage    Gynecologic Cancer

One Of The Youngest Ovarian Cancer Victims Remembered: ‘She Never Stopped Fighting’

Peyton taught the world that ovarian cancer doesn’t just strike mothers and grandmothers. “She’s brought so much awareness to the disease through her advocacy,” said CU Cancer Center member Saketh Guntupalli, MD. 


Author CBS4 Denver | Publish Date January 08, 2021
Full Story

Research    Gynecologic Cancer    Ovarian Cancer

CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes

After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.


Author Cancer Center | Publish Date September 15, 2020
Full Story

Research    Gynecologic Cancer    Cervical Cancer

American Cancer Society Releases Simplified Cervical Cancer Screening Guidelines

Last month the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The most notable change in guidelines is the changes in the age to begin screening. Per the new guidelines, it is recommended that cervical cancer screening begin at age 25. Previously, the starting age for screening was 21.


Author Cancer Center | Publish Date August 18, 2020
Full Story

Philanthropy    Gynecologic Cancer    Cancer    Ovarian Cancer

Building Towards Early Detection of Ovarian Cancer

In July 2019, Emily McClintock Addlesperger was on vacation in Maine with her husband, Jason, when she felt sick and was airlifted to Portland with internal bleeding. A tumor on her ovary had burst. It was Monday. On Saturday, she passed away. Emily was 44 years old.


Author Cancer Center | Publish Date July 16, 2020
Full Story

Gynecologic Cancer    Clinical Research

A Slippery Slope to the Operating Room

Brad Corr’s inspiration to pursue a medical career came on the ski slopes of Big Sky, Montana.


Author Cancer Center | Publish Date February 03, 2020
Full Story

Gynecologic Cancer    Women's Health    Advocacy    Cervical Cancer

Cervical cancer survivor: Don’t miss your Pap smears!

Debbie Garcia always dreamed of having a big family.


Author Cancer Center | Publish Date January 17, 2020
Full Story

Gynecologic Cancer

Saketh Guntupalli on leadership vision, higher survival rates for gynecologic cancers

This July, University of Colorado Cancer Center investigator, Saketh Guntupalli, MD, assumes the role of Division Chief of the CU School of Medicine Department of Obstetrics and Gynecology Division of Gynecologic Oncology, with a mission to increase the excellence of clinical care, train the next generation of physician-scientists, and move the needle on gynecologic cancer research. Guntupalli takes over a program that already boasts 15-20 percent improved survival rates over national averages for some cancers including uterine cancer.


Author Cancer Center | Publish Date July 01, 2019
Full Story

Gynecologic Cancer

ASCO: Sexual health interventions after treatment are an unmet need for gynecologic cancer patients

Sexual health can be an uncomfortable subject after completing cancer treatment, but is an important quality of life issue. A University of Colorado Cancer Center study presented at the 2019 American Society of Clinical Oncology (ASCO) conference in Chicago highlights the unmet need of interventions to improve and maintain optimal sexual health. 


Author Cancer Center | Publish Date May 31, 2019
Full Story

Gynecologic Cancer

Take the Tubes but Leave the Ovaries: Salpingectomy an Evolving Option for Young Women at High Risk for Gynecologic Cancers

In women at high risk for ovarian cancer, the common prevention strategy is to remove fallopian tubes and ovaries as soon as the woman is done having a family – the sooner the better. But this initiates menopause and along with it higher risk of cardiovascular disease, osteoporosis, sexual side-effects, and perhaps even Alzheimer’s disease. A recent University of Colorado Cancer Center review in the International Journal of Gynecologic Cancer suggests a way young, high-risk women can reduce risk while leaving menopause for later: the technique known as salpingectomy removes the fallopian tubes while leaving ovaries intact.


Author Garth Sundem | Publish Date February 20, 2013
Full Story

CU Cancer Center In the News

OncLive

The Role of mTOR/Aurora A Kinase Combination Therapy Requires Further Elucidation in Solid Tumors

news outletOncLive
Publish DateJuly 08, 2024

CU Cancer Center member S. Lindsey Davis, MD, highlighted that the combination therapy of sapanisertib and alisertib showed marginal clinical benefit for patients with advanced solid tumors, correlative analyses suggested that apoptotic response and tumor immune cell infiltrate might influence clinical outcomes. The phase 1b study's expansion cohort indicated some positive outlying responses among patients and underscore the need for further research to tailor treatments for standout patients and explore rational combinations to enhance efficacy.

Full Story
News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story